Intensity Average Receivables from 2010 to 2026
| INTS Stock | 0.37 0 0.97% |
Average Receivables | First Reported 2010-12-31 | Previous Quarter 44.9 K | Current Value 36.4 K | Quarterly Volatility 4.2 K |
Check Intensity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intensity Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 379.2 K, Interest Income of 379.2 K or Depreciation And Amortization of 21.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 7.93. Intensity financial statements analysis is a perfect complement when working with Intensity Therapeutics Valuation or Volatility modules.
Intensity | Average Receivables | Build AI portfolio with Intensity Stock |
The evolution of Average Receivables for Intensity Therapeutics Common provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Intensity Therapeutics compares to historical norms and industry peers.
Latest Intensity Therapeutics' Average Receivables Growth Pattern
Below is the plot of the Average Receivables of Intensity Therapeutics Common over the last few years. It is Intensity Therapeutics' Average Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Intensity Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Average Receivables | 10 Years Trend |
|
Average Receivables |
| Timeline |
Intensity Average Receivables Regression Statistics
| Arithmetic Mean | 43,100 | |
| Geometric Mean | 42,919 | |
| Coefficient Of Variation | 9.67 | |
| Mean Deviation | 3,408 | |
| Median | 41,078 | |
| Standard Deviation | 4,167 | |
| Sample Variance | 17.4M | |
| Range | 13.5K | |
| R-Value | 0.44 | |
| Mean Square Error | 14.9M | |
| R-Squared | 0.19 | |
| Significance | 0.08 | |
| Slope | 362.52 | |
| Total Sum of Squares | 277.8M |
Intensity Average Receivables History
About Intensity Therapeutics Financial Statements
Intensity Therapeutics shareholders use historical fundamental indicators, such as Average Receivables, to determine how well the company is positioned to perform in the future. Although Intensity Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Intensity Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Intensity Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Average Receivables | 44.9 K | 36.4 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Intensity Stock Analysis
When running Intensity Therapeutics' price analysis, check to measure Intensity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intensity Therapeutics is operating at the current time. Most of Intensity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Intensity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intensity Therapeutics' price. Additionally, you may evaluate how the addition of Intensity Therapeutics to your portfolios can decrease your overall portfolio volatility.